ARCHIVES

RG7204 Meets Endpoints Of Extending Survival, PFS

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

August 8, 2014

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

Emory, Children’s Strengthen Ties

May 25, 2001

Lung, Head & Neck Treatment Advances Reported At ASCO Annual Meeting

May 27, 1977

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013